- Home
- HALO vs EMN Comparison
HALO vs EMN Comparison
Compare HALO & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HALO | EMN |
|---|---|---|
| Founded | 1998 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.1B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | HALO | EMN |
|---|---|---|
| Price | $70.35 | $66.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $76.42 | ★ $78.54 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 02-17-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 4.89% |
| EPS Growth | ★ 56.68 | N/A |
| EPS | 4.74 | ★ 6.01 |
| Revenue | $1,242,852,000.00 | ★ $9,024,000,000.00 |
| Revenue This Year | $34.54 | N/A |
| Revenue Next Year | $26.28 | $0.35 |
| P/E Ratio | $15.04 | ★ $11.43 |
| Revenue Growth | ★ 31.19 | N/A |
| 52 Week Low | $47.50 | $56.11 |
| 52 Week High | $79.50 | $103.82 |
Technical Indicators
Market Signals| Indicator | HALO | EMN |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 50.82 |
| Support Level | $70.75 | $65.51 |
| Resistance Level | $74.08 | $70.40 |
| Average True Range (ATR) | 2.07 | 2.00 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 40.32 | 38.43 |
Price Performance
Historical ComparisonAbout HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About EMN Eastman Chemical Company
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.